Results
|
1.
|
Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology). MedStar authors:
Year: 2017
Citation: - Journal of Clinical Oncology. 35(23):2647-2655, 2017 Aug 10.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Randomized Controlled Trial
All authors: - Asmar L, Blum JL, Brufsky AM, Colangelo LH, Dang CT, Fehrenbacher L, Flynn PJ, Geyer CE Jr, Gomez HL, Hopkins JO, Jacobs SA, Jeong JH, Jones SE, Lyss AP, Mamounas EP, O'Shaughnessy JA, Paul D, Robert NJ, Swain SM, Vukelja SJ, Wolmark N, Yothers G
|
|
2.
|
|
|
3.
|
|
|
4.
|
Reply to a. Avan et Al. MedStar authors:
Year: 2015
Citation: - Journal of Clinical Oncology. 33(15):1712, 2015 May 20.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Baselga J, Clark E, Kiermaier A, Swain S
|
|
5.
|
|
|
6.
|
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study. MedStar authors:
Year: 2013
Citation: - Lancet Oncology. 14(6):461-71, 2013 May.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Benyunes MC, Campone M, Ciruelos E, Clark E, Cortes J, Ferrero JM, Kim SB, Knott A, Ro J, Ross G, Schneeweiss A, Semiglazov V, Swain SM
|
|
7.
|
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. MedStar authors:
Year: 2012
Citation: - Lancet. 379(9814):432-44, 2012 Feb 4.
Institution: - Washington Cancer Institute
Medline publication type:
- Comparative Study
- Journal Article
- Meta-Analysis
- Research Support, Non-U.S. Gov't
All authors: - Albain K, Bergh J, Clarke M, Cutter D, Darby S, Davies C, Di Leo A, Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Godwin J, Gray R, McGale P, Pan HC, Peto R, Piccart M, Pritchard K, Swain S, Taylor C, Wang YC
|
|
8.
|
Twenty-five year results of the national cancer institute randomized breast conservation trial. MedStar authors:
Year: 2012
Citation: - Breast Cancer Research & Treatment. 132(1):197-203, 2012 Feb.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Camphausen K, Dan T, Danforth DN, Glatstein E, Lippman ME, Lita E, Sciuto L, Shih J, Simone NL, Smith SL, Swain SM
|
|
9.
|
Pazopanib for the treatment of breast cancer. [Review] MedStar authors:
Year: 2012
Citation: - Expert Opinion on Investigational Drugs. 21(2):217-25, 2012 Feb.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Review
All authors: - Amiri-Kordestani L, Swain SM, Tan AR
|
|
10.
|
Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24. MedStar authors:
Year: 2012
Citation: - Journal of Clinical Oncology. 30(12):1268-73, 2012 Apr 20.
Institution: - Washington Cancer Institute
Medline publication type:
- Comparative Study
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Allred DC, Anderson SJ, Costantino JP, Geyer CE Jr, Julian TB, Land SR, Mamounas EP, Nagtegaal ID, Paik S, Swain SM, Wickerham DL, Wolmark N
|
|
11.
|
Bevacizumab added to neoadjuvant chemotherapy for breast cancer. MedStar authors:
Year: 2012
Citation: - New England Journal of Medicine. 366(4):310-20, 2012 Jan 26.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, P.H.S.
All authors: - Adams PT, Atkins JN, Baez-Diaz L, Bear HD, Brufsky AM, Costantino JP, Fehrenbacher L, Gaur R, Geyer CE Jr, Gross HM, Mamounas EP, Margolese RG, Mehta RS, Rastogi P, Robidoux A, Senecal FM, Swain SM, Tang G, Wolmark N, Young JA
|
|
12.
|
Evaluation of lymphangiogenic factors, vascular endothelial growth factor D and E-cadherin in distinguishing inflammatory from locally advanced breast cancer. MedStar authors:
Year: 2012
Citation: - Clinical Breast Cancer. 12(4):232-9, 2012 Aug.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Intramural
- Research Support, U.S. Gov't, Non-P.H.S.
All authors: - Duong QN, Hewitt SM, Hoffman HJ, Levine PH, Portera CC, Swain SM, Takikita M, Yang SX
|
|
13.
|
Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial. MedStar authors:
Year: 2012
Citation: - Lancet Oncology. 13(7):734-42, 2012 Jul.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Anderson SJ, Baez-Diaz L, Brufsky AM, Costantino JP, Dakhil S, Falkson CI, Fehrenbacher L, Geyer CE Jr, Gralow JR, King KM, Lad T, Lembersky BC, Mamounas EP, Paterson AH, Perez EA, Robidoux A, Swain SM, Weir LM, Wolmark N, Zheng P
|
|
14.
|
Patient navigation significantly reduces delays in breast cancer diagnosis in the District of Columbia. MedStar authors:
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
All authors: - Alexander LM, Brem R, Caicedo L, Eng-Wong J, Frederick W, Funderburk W, Hoffman HJ, Huerta E, LaVerda NL, Levine PH, Patierno SR, Swain S, Young HA
|
|
15.
|
|
|
16.
|
Cardiac tolerability of pertuzumab plus trastuzumab plus docetaxel in patients with HER2-positive metastatic breast cancer in CLEOPATRA: a randomized, double-blind, placebo-controlled phase III study. MedStar authors:
Year: 2013
Citation: - Oncologist. 18(3):257-64, 2013.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Amadori D, Baselga J, Benyunes MC, Clark E, Cortes J, Ewer MS, Knott A, Miles D, Ross G, Swain SM
|
|
17.
|
|
|
18.
|
Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31. MedStar authors:
Year: 2013
Citation: - Journal of the National Cancer Institute. 105(23):1782-8, 2013 Dec 4.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Bandos H, Blackmon NL, Bohn OL, Burandt E, Costantino JP, Fehrenbacher L, Fumagalli D, Gavin PG, Geyer CE Jr, Goldstein LC, Horne ZD, Jeong JH, Kim C, Kim SI, Kim SR, Lee A, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Reilly ML, Remillard MY, Romond EH, Sneige N, Swain SM, Tanaka N, Taniyama Y, Wickerham DL, Wolmark N
|
|
19.
|
|
|
20.
|
Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial. MedStar authors:
Year: 2013
Citation: - Lancet Oncology. 14(12):1183-92, 2013 Nov.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Atkins JN, Azar CA, Baez-Diaz L, Bandos H, Bear HD, Brufsky AM, Costantino JP, Farrar WB, Fehrenbacher L, Geyer CE Jr, Mamounas EP, Margolese RG, Paik S, Rastogi P, Robidoux A, Sarwar S, Shibata HR, Swain SM, Tang G, Wolmark N
|
|
21.
|
Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial. MedStar authors:
Year: 2013
Citation: - Journal of Clinical Oncology. 31(26):3197-204, 2013 Sep 10.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
All authors: - Atkins JN, Azar CA, Biggs DD, Brufsky AM, Costantino JP, Donnellan PP, Fehrenbacher L, Geyer CE Jr, Levine EA, Mamounas EP, Northfelt DW, Paik S, Polikoff JA, Provencher L, Rastogi P, Robidoux A, Swain SM, Tang G, Wolmark N, Zapas JL
|
|
22.
|
Assessment of diagnosis of inflammatory breast cancer cases at two cancer centers in Egypt and Tunisia. MedStar authors:
Year: 2013
Citation: - Cancer Medicine. 2(2):178-84, 2013 Apr.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Intramural
All authors: - Ayed FB, Ayoub WB, Brown LM, Eissa S, Gail M, Kantor ED, Khalafallah S, Khaled H, Merajver S, Omar S, Schairer C, Soliman AS, Swain SM
|
|
23.
|
Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA). MedStar authors:
Year: 2013
Citation: - Breast Cancer Research & Treatment. 142(1):89-99, 2013 Nov.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Amadori D, Baselga J, Clark E, Knott A, Miles D, Ross G, Semiglazov V, Sunpaweravong P, Swain SM
|
|
24.
|
Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer. MedStar authors:
Year: 2013
Citation: - Annals of Oncology. 24(10):2630-5, 2013 Oct.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Clark E, Cortes J, Im SA, Im YH, Knott A, Pivot X, Ross G, Swain SM
|
|
25.
|
Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancer. MedStar authors:
Year: 2014
Citation: - Journal of Clinical Oncology. 32(14):1427-36, 2014 May 10.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Ales-Martinez JE, Brundage M, Cheung AM, Chlebowski RT, Cooke AL, Dube P, Ellard SL, Fabian CJ, Gelmon KA, Goss PE, Hendrix S, Hiltz A, Ingle JN, Johnston D, Lickley L, Maunsell E, Pater JL, Pruthi S, Pujol P, Richardson H, Rowland KM, Ruiz A, Sarto GE, Spadafora S, Thayer DW, Tu D, Wactawski-Wende J
|
|
26.
|
Reply to E.J. Moylan et al. MedStar authors:
Year: 2014
Citation: - Journal of Clinical Oncology. 32(6):606-7, 2014 Feb 20.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Geyer CE Jr, Swain SM, Tang G
|
|
27.
|
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. [Review] MedStar authors:
Year: 2014
Citation: - Lancet. 384(9938):164-72, 2014 Jul 12.
Medline publication type:
- Journal Article
- Meta-Analysis
- Research Support, U.S. Gov't, P.H.S.
- Review
All authors: - Baselga J, Bergh J, Blohmer J, Blumenthal G, Bogaerts J, Bonnefoi H, Cameron D, Cortazar P, Costantino JP, Ditsch N, Eidtmann H, Eiermann W, Fasching PA, Gerber B, Geyer CE Jr, Gianni L, Justice R, Loibl S, Mamounas EP, Mehta K, Paik S, Pazdur R, Perou C, Piccart M, Prowell T, Rastogi P, Semiglazov V, Slaets L, Sridhara R, Swain SM, Tang S, Untch M, Valagussa P, von Minckwitz G, Wickerham DL, Wolmark N, Zhang L
|
|
28.
|
Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer. MedStar authors:
Year: 2014
Citation: - Cancer. 120(17):2657-64, 2014 Sep 1.
Institution: - Washington Cancer Institute
Medline publication type:
- Comparative Study
- Journal Article
- Multicenter Study
- Observational Study
- Research Support, Non-U.S. Gov't
All authors: - Bloom KJ, Brammer MG, Burris H, Chau M, Gralow JR, Kaufman PA, Lalla D, Mayer M, Pegram M, Rugo HS, Swain SM, Vogel CL, Yardley DA, Yoo B
|
|
29.
|
Absence of pharmacokinetic drug-drug interaction of pertuzumab with trastuzumab and docetaxel. MedStar authors:
Year: 2013
Citation: - Anti-Cancer Drugs. 24(10):1084-92, 2013 Nov.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Brewster M, Cortes J, Garg A, Grincuka E, Hauschild M, Kudaba I, Lum BL, Marier JF, Masuda N, McNally V, Nijem I, Patel T, Ross G, Swain SM, Trinh MM, Visich J
|
|
30.
|
Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer. MedStar authors:
Year: 2014
Citation: - Journal of Clinical Oncology. 32(33):3753-61, 2014 Nov 20.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Clark E, Cortes J, Im SA, Kiermaier A, Ross G, Swain SM
|
|
31.
|
Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA. MedStar authors:
Year: 2014
Citation: - Annals of Oncology. 25(6):1116-21, 2014 Jun.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Cortes J, Im YH, Lee LF, Miles D, Quah C, Swain SM
|
|
32.
|
Pertuzumab for the treatment of breast cancer. [Review] MedStar authors:
- Lynce, Filipa
- Swain, Sandra M
Year: 2014
Citation: - Cancer Investigation. 32(8):430-8, 2014 Oct.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, Non-U.S. Gov't
- Review
|
|
33.
|
The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. MedStar authors:
Year: 2014
Citation: - BMC Cancer. 14:307, 2014.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Beattie M, Hurvitz S, Jahanzeb M, Kaufman PA, Lai C, Masaquel A, Mason G, O'Shaughnessy J, Rugo HS, Swain S, Tripathy D, Yoo B
|
|
34.
|
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. MedStar authors:
Year: 2015
Citation: - New England Journal of Medicine. 372(8):724-34, 2015 Feb 19.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Benyunes MC, Campone M, Ciruelos E, Clark E, CLEOPATRA Study Group, Cortes J, Ferrero JM, Heeson S, Kim SB, Ro J, Ross G, Schneeweiss A, Semiglazov V, Swain SM
|
|
35.
|
Treatment of HER2-positive metastatic breast cancer. MedStar authors:
Year: 2015
Citation: - New England Journal of Medicine. 372(20):1964-5, 2015 May 14.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Baselga J, Clark E, Swain SM
|
|
36.
|
|
|
37.
|
Intrinsic subtypes, PIK3CA mutation, and the degree of benefit from adjuvant trastuzumab in the NSABP B-31 trial. MedStar authors:
Year: 2015
Citation: - Journal of Clinical Oncology. 33(12):1340-7, 2015 Apr 20.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Blackmon NL, Costantino JP, Fehrenbacher L, Finnigan M, Gavin PG, Geyer CE Jr, Jeong JH, Kim SR, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Song N, Swain SM, Wickerham DL, Wolmark N
|
|
38.
|
Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study. [] MedStar authors:
Year: 2015
Citation: - Breast Cancer Research & Treatment. 149(1):163-9, 2015 Jan.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Bhatt K, Bury MJ, Fehrenbacher L, Flynn PJ, Geyer CE Jr, Goel R, Jacobs SA, Johannes H, Julian TB, Mamounas EP, Provencher L, Rastogi P, Robidoux A, Stella PJ, Swain SM, Tan AR, Thirlwell MP, Wolmark N
|
|
39.
|
Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831. MedStar authors:
Year: 2014
Citation: - Journal of Clinical Oncology. 32(33):3744-52, 2014 Nov 20.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Colon-Otero G, Davidson NE, Geyer CE Jr, Gralow J, Jeong JH, Mamounas E, Martino S, Perez EA, Rastogi P, Romond EH, Sledge G, Suman VJ, Swain SM, Winer EP, Wolmark N, Zujewski JA
|
|
40.
|
Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial. MedStar authors:
Year: 2015
Citation: - Lancet Oncology. 16(9):1037-48, 2015 Sep.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Adams PT, Baez-Diaz L, Bear HD, Brufsky AM, Costantino JP, Fehrenbacher L, Gaur R, Geyer CE Jr, Gross HM, Liu Q, Mamounas EP, Margolese RG, Mehta RS, Paik S, Rastogi P, Robidoux A, Senecal FM, Swain SM, Tang G, Wolmark N, Young JA
|
|
41.
|
Deleterious BRCA1/2 mutations in an urban population of Black women. MedStar authors:
- Fries, Melissa
- Lynce, Filipa
Year: 2015
Citation: - Breast Cancer Research & Treatment. 153(1):201-9, 2015 Aug.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - DeMarco T, Fries M, Isaacs C, Lynce F, Peshkin BN, Smith KL, Stein J, Wang H, Wang Y
|
|
42.
|
Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials. MedStar authors:
Year: 2015
Citation: - JAMA Oncology. 1(3):296-305, 2015 Jun.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
All authors: - Adams-Campbell LL, Aragaki AK, Chlebowski RT, Johnson KC, Kaunitz A, Lessin LS, Manson JE, Nassir R, O'Sullivan MJ, Prentice RL, Rohan TE, Simon MS, Stefanick ML, Wactawski-Wende J
|
|
43.
|
|
|
44.
|
|
|
45.
|
|
|
46.
|
The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl. MedStar authors:
Year: 2016
Citation: - Breast Cancer Research & Treatment. 155(2):235-51, 2016 Jan.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Amiri-Kordestani L, Chavez KJ, Conway CM, Dine JL, Greer YE, Hewitt SM, Lipkowitz S, Merchant AS, O'Sullivan CC, Sinclair S, Steinberg SM, Stone B, Swain SM, Voeller D
|
|
47.
|
Cardiac function in BRCA1/2 mutation carriers with history of breast cancer treated with anthracyclines. MedStar authors:
- Asch, Federico M
- Barac, Ana
- Herbolsheimer, Pia M
- Lynce, Filipa
- Mete, Mihriye
- Nunes, Raquel
- Shara, Nawar M
- Swain, Sandra M
- Wray, Lynette
Year: 2016
Citation: - Breast Cancer Research & Treatment. 155(2):285-93, 2016 Jan.
Institution:
- MedStar Health Research Institute
- MedStar Health Research Institute
- MedStar Health Research Institute
- MedStar Washington Hospital Center
- MedStar Washington Hospital Center
- Washington Cancer Institute
- Washington Cancer Institute
- Washington Cancer Institute A
- Washington Cancer Instituteia
Department:
- MedStar Heart Institute
- MedStar Heart Institute
Medline publication type:
All authors: - Asch FM, Barac A, Herbolsheimer P, Isaacs C, Lynce F, Mete M, Nardacci MP, Nunes RA, Peshkin BN, Shara NM, Smith KL, Swain SM, Warren R, Wray L
|
|
48.
|
Body Mass Index at Diagnosis and Breast Cancer Survival Prognosis in Clinical Trial Populations from NRG Oncology/NSABP B-30, B-31, B-34, and B-38. MedStar authors:
Year: 2016
Citation: - Cancer Epidemiology, Biomarkers & Prevention. 25(1):51-9, 2016 Jan.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
All authors: - Anderson SJ, Cecchini RS, Costantino JP, Geyer CE Jr, Jeong JH, Lembersky BC, Paterson AH, Rastogi P, Romond EH, Swain SM, Tang G, Wolmark N
|
|
49.
|
Cardiovascular Disease After Aromatase Inhibitor Use. MedStar authors:
Year: 2016
Citation: - JAMA Oncology. 2(12):1590-1597, 2016 Dec 01
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Amundsen B, Avila C, Barac A, Chlebowski RT, Chung J, Haque R, Schottinger JE, Shi J, Xu X
|
|
50.
|
|
|
51.
|
|
|
52.
|
Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2-Positive Breast Cancer: Analysis of the NSABP B-31 Trial. MedStar authors:
Year: 2017
Citation: - JAMA Oncology. 3(3):335-341, 2017 Mar 01
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
All authors: - Bandos H, Costantino JP, Fehrenbacher L, Finnigan M, Gavin PG, Geyer CE Jr, Jeong JH, Johnson NL, Kim SR, Lipchik C, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Song N, Swain SM, Wickerham DL, Wolmark N
|
|
53.
|
|
|
54.
|
Good News, Bad News, but Not Fake News. MedStar authors:
Year: 2017
Citation: - Circulation. 135(15):1413-1416, 2017 Apr 11
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
|
|
55.
|
|
|
56.
|
Erosive Breast Cancer Metastasis to the Ankle: A Case Report. MedStar authors:
Year: 2016
Citation: - Journal of Foot & Ankle Surgery. 55(6):1297-1301, 2016 Nov - Dec
Institution: - Medstar Franklin Square Medical Center
Department: - Harry and Jeanette Weinberg Cancer Institute,
Medline publication type:
- Case Reports
- Journal Article
All authors: - Aboulafia A, Jaffe D, Kim E
|
|
57.
|
Low-Fat Dietary Pattern and Breast Cancer Mortality in the Women's Health Initiative Randomized Controlled Trial. MedStar authors:
Year: 2017
Citation: - Journal of Clinical Oncology. 35(25):2919-2926, 2017 Sep 01
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Anderson GL, Aragaki AK, Barrington W, Chlebowski RT, Hou L, Howard BV, Lane D, Manson JE, Prentice RL, Qi L, Rohan TE, Simon MS, Snetselar L, Thomas F, Thomson CA, Vitolins MZ, Womack C
|
|
58.
|
Race or Resource? BMI, Race, and Other Social Factors as Risk Factors for Interlimb Differences among Overweight Breast Cancer Survivors with Lymphedema. MedStar authors:
Year: 2016
Citation: - Journal of Obesity. 2016:8241710, 2016
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Brown JC, Cheville A, Dean LT, Evangelisti M, Hackley R, Herling M, Kim J, Kim T, Kumar A, Schmitz KH, Schwartz JS, Troxel AB, Zhang Z
|
|
59.
|
|
|
60.
|
Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5. MedStar authors:
Year: 2017
Citation: - Clinical Breast Cancer. 17(1):48-54.e3, 2017 Feb
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Ansari B, Buyse ME, Conlin AK, Geyer CE Jr, Gross HM, Jacobs SA, Keogh GP, Lord RS, Mamounas EP, Mauquoi C, Patocskai EJ, Polikoff JA, Rastogi P, Robidoux A, Smith JW 2nd, Stella PJ, Swain SM, Wolmark N
|
|
61.
|
Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30. MedStar authors:
- McCarron, Edward C
- Swain, Sandra M
Year: 2018
Citation: - Journal of the National Cancer Institute. 110(2), 2018 Feb 01
Institution:
- MedStar Franklin Square Medical Center
- Washington Cancer Institute
Medline publication type:
All authors: - Bandos H, Brufsky AM, Fehrenbacher L, Ganz PA, Julian TB, Margolese RG, McCarron EC, Melnikow J, Rivera DR, Sturtz K, Swain SM, Wade JL 3rd
|
|
62.
|
|
|
63.
|
The effect of genetic variants on the relationship between statins and breast cancer in postmenopausal women in the Women's Health Initiative observational study. MedStar authors:
Year: 2018
Citation: - Breast Cancer Research & Treatment. 167(3):741-749, 2018 02.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Beebe-Dimmer JL, Bock CH, Cote ML, Desai P, Dyson G, Hou L, Howard BV, Jay AM, Prentice R, Purrington K, Simon MS
|
|
64.
|
Characteristics and outcomes of breast cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase I clinical trials. MedStar authors:
- Blackburn, Matthew J
- Lynce, Filipa
Year: 2018
Citation: - Breast Cancer Research & Treatment. 168(1):35-41, 2018 Feb.
Institution:
- MedStar Washington Hospital Center
- Washington Cancer Institute
Medline publication type:
All authors: - Blackburn MJ, Cai L, Harris P, Isaacs C, Lynce F, Pohlmann PR, Rubinstein L, Wang H
|
|
65.
|
Prepectoral Breast Reconstruction. [Review] MedStar authors:
Year: 2017
Citation: - Plastic & Reconstructive Surgery. 140(5S Advances in Breast Reconstruction):51S-59S, 2017 Nov
Medline publication type:
All authors: - Nahabedian MY, Ter Louw RP
|
|
66.
|
Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2. MedStar authors:
- Swain, Sandra M
- Zapas, John L
Year: 2017
Citation: - Journal of Clinical Oncology. 35(35):3942-3948, 2017 Dec 10
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Atkins JN, Biggs DD, Brufsky AM, Cecchini RS, Fehrenbacher L, Flynn PJ, Ganz PA, Geyer CE Jr, Gross HM, Jeong JH, Mamounas EP, Polikoff J, Rastogi P, Romond EH, Seay TE, Swain SM, Wade JL 3rd, Wahl TA, Wolmark N, Zapas JL
|
|
67.
|
Adjuvant Radiotherapy in Early-Stage Breast Cancer: Evidence-Based Options. [Review] MedStar authors:
Year: 2016
Citation: - Annals of Surgical Oncology. 23(12):3880-3890, 2016 Nov
Institution: - MedStar Shah Health Group
Medline publication type:
All authors: - Arthur D, Balagamwala E, Khan A, Manyam B, Nanavati A, Pham Y, Shah C, Smile T, Takiar R, Tendulkar R, Vicini F, Wazer D, Wobb J
|
|
68.
|
TARGIT-R (Retrospective): North American Experience with Intraoperative Radiation Using Low-Kilovoltage X-Rays for Breast Cancer. MedStar authors:
Year: 2016
Citation: - Annals of Surgical Oncology. 23(9):2809-15, 2016 Sep
Medline publication type:
- Journal Article
- Multicenter Study
All authors: - Abbott AM, Andolino DL, Bailey L, Bedi GC, Bethke KP, Boisvert ME, Bravo L, Cherian S, Collins BT, Deb N, Donnelly ED, Eaker JA, Escallon JM, Friedman NB, Fyles AW, Graves GM, Graves J, Greif JM, Grobmyer SR, Hermanto U, Hoefer RA, Joh JE, Kang SK, Kelemen P, Kelly T, Laronga C, Loftus L, Lottich SC, Lyons J, McCready DR, O'Rourke C, Pederson A, Police A, Riley L, Rohatgi N, Rosen B, Ross DL, Rudolph R, Ruffer J, Shaw CM, Small W Jr, Summer T, Tendulkar RD, Thompson WA 3rd, Tousimis EA, Uhl V, Valente SA, Willey SC, Wilson JP
|
|
69.
|
SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function. MedStar authors:
- Asch, Federico M
- Barac, Ana
- Lynce, Filipa
- Swain, Sandra M
Year: 2017
Citation: - Oncologist. 22(5):518-525, 2017 May
Institution:
- MedStar Heart & Vascular Institute
- Washington Cancer Institute
Medline publication type:
All authors: - Asch FM, Barac A, Dang C, Isaacs C, Lynce F, Smith KL, Swain SM, Tan MT
|
|
70.
|
Delayed Recurrent and Bilateral Breast Cancer in Patients With Partial Poland's Anomaly: Report of 2 Rare Cases and Review of the Literature. MedStar authors:
- Bozzuto, Laura M
- DeFazio, Michael V
- Dervishaj, Ornela A
Year: 2018
Citation: - Clinical Breast Cancer. 18(3):e285-e290, 2018 06.
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Bozzuto LM, DeFazio MV, Dervishaj OA, Olding MJ, Pittman TA, Tousimis EA, Willey SC
|
|
71.
|
|
|
72.
|
The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40. MedStar authors:
Year: 2016
Citation: - Annals of Surgical Oncology. 24(7):1853-1860, 2017 Jul
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Adams PT, Baez-Diaz L, Bear HD, Brufsky AM, Costantino JP, Fehrenbacher L, Gaur R, Geyer CE Jr, Gross HM, Kidwell KM, Mamounas EP, Margolese RG, Mehta RS, Paik S, Rastogi P, Robidoux A, Senecal FM, Swain SM, Tang G, Wolmark N, Young JA, Zoon CK
|
|
73.
|
|
|
74.
|
|
|
75.
|
|
|
76.
|
Sedentary time and postmenopausal breast cancer incidence. MedStar authors:
Year: 2017
Citation: - Cancer Causes & Control. 28(12):1405-1416, 2017 Dec.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Adams-Campbell LL, Allison M, Barrington W, Bowen D, Chlebowski R, Coday M, Dash C, Hou L, Howard B, LaMonte M, Manson JE, Neuhouser ML, Nomura SJO, Paskett E, Sattari M, Sheppard VB, Stefanick M, Wactawski-Wende J
|
|
77.
|
Positive Nipple Margin After Nipple-Sparing Mastectomy: An Alternative and Oncologically Safe Approach to Preserving the Nipple-Areolar Complex. MedStar authors:
- Gulla, Aiste
- Haslinger, Michelle L
- Sosin, Michael
Year: 2018
Citation: - Annals of Surgical Oncology. 25(8):2303-2307, 2018 Aug.
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Bartholomew AJ, Crocker A, Gulla A, Haslinger ML, Pittman TA, Sosin M, Tousimis EA, Willey SC
|
|
78.
|
The Use of Low-profile Silicone Breast Implants in Male Breast Reconstruction. MedStar authors:
- Bamba, Ravinder
- Economides, James M
- Pittman, Troy A
- Youn, Richard
Year: 2017
Citation: - Plastic & Reconstructive Surgery. 141(2):324e-325e, 2018 02.
Institution: - MedStar Washington Hospital Center
Department:
- Surgery/General Surgery
- Surgery/Plastic Surgery
Medline publication type:
All authors: - Bamba R, Economides JM, Krishnan NM, Pittman TA, Youn R
|
|
79.
|
Onco-metabolism: defining the prognostic significance of obesity and diabetes in women with brain metastases from breast cancer. MedStar authors:
Year: 2018
Citation: - Breast Cancer Research & Treatment. 172(1):221-230, 2018 Nov.
Institution: - MedStar Franklin Square Medical Center
Medline publication type:
All authors: - Andrews DW, Anne' PR, Dicker AP, Ko K, McCall NS, Mehta M, Nowak-Choi K, Rese A, Shi W, Simone BA, Simone NL, Venkataraman C, Zhan T
|
|
80.
|
Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial. MedStar authors:
Year: 2019
Citation: - Lancet Oncology. 20(1):88-99, 2019 01.
Institution: - MedStar Franklin Square Medical Center
Medline publication type:
All authors: - Bandos H, Brufsky AM, Chia SK, Dakhil SR, Fehrenbacher L, Geyer CE Jr, Graham ML, Jeong JH, Lembersky BC, Mamounas EP, McCarron EC, Paik S, Rastogi P, Seay TE, Soori GS, Swain SM, Wade JL 3rd, Walshe JM, Wickerham DL, Wolmark N
|
|
81.
|
|
|
82.
|
Breast Cancer and Heart Failure. [Review] MedStar authors:
Year: 2019
Citation: - Heart Failure Clinics. 15(1):65-75, 2019 Jan.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Almuwaqqat Z, Barac A, Meisel JL, Parashar S
|
|
83.
|
|
|
84.
|
|
|
85.
|
|
|
86.
|
|
|
87.
|
Neoadjuvant Chemotherapy and Nipple-Sparing Mastectomy: Timing and Postoperative Complications. MedStar authors:
- Dervishaj, Ornela A
- Tung, Shawndeep S
Year: 2019
Citation: - Annals of Surgical Oncology. 26(9):2768-2772, 2019 Sep.
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Bartholomew AJ, Caragacianu DL, Dervishaj OA, Kerivan LT, Sosin M, Tousimis EA, Tung SS, Willey SC
|
|
88.
|
|
|
89.
|
Low-Fat Dietary Pattern among Postmenopausal Women Influences Long-Term Cancer, Cardiovascular Disease, and Diabetes Outcomes. MedStar authors:
Year: 2019
Citation: - Journal of Nutrition. 149(9):1565-1574, 2019 09 01.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Anderson GL, Aragaki AK, Chlebowski RT, Howard BV, Johnson KC, Kuller LE, Manson JE, Neuhouser ML, Prentice RL, Rossouw JE, Snetselaar L, Thomson CA, Tinker LF, Van Horn L
|
|
90.
|
Physician Perspectives on Fertility Preservation Discussions with Premenopausal Breast Cancer Patients: Results from a Multihospital Health Care System. MedStar authors:
- Bozzuto, Laura M
- Haslinger, Michelle
- Thibodeau, Renee
- Tsiapali, Ekaterini V
- Tung, Shawndeep S
Year: 2019
Citation: - Annals of Surgical Oncology. 2019 Jul 24
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Bartholomew AJ, Bozzuto LM, Haslinger M, Masciello MC, Thibodeau R, Tsiapali EV, Tung SS
|
|
91.
|
Menopausal Estrogen-Alone Therapy and Health Outcomes in Women With and Without Bilateral Oophorectomy: A Randomized Trial. MedStar authors:
Year: 2019
Citation: - Annals of Internal Medicine. 171(6):406-414, 2019 09 17.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Anderson GL, Aragaki AK, Bassuk SS, Chlebowski RT, Crandall CJ, Eaton CB, Henderson VW, Howard BV, Kaunitz AM, Liu S, Luo J, Manson JE, Prentice RL, Rohan T, Rossouw JE, Shadyab AH, Stefanick ML, Thomson CA, Wactawski-Wende J, Wells G, WHI Investigators
|
|
92.
|
|
|
93.
|
Trastuzumab-Induced Cardiomyopathy. [Review] MedStar authors:
Year: 2019
Citation: - Cardiology Clinics. 37(4):407-418, 2019 Nov.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Barac A, Barish R, Gates E
|
|
94.
|
|
|
95.
|
|
|
96.
|
|
|
97.
|
|
|
98.
|
Dietary Modification and Breast Cancer Mortality: Long-Term Follow-Up of the Women's Health Initiative Randomized Trial. MedStar authors:
Year: 2020
Citation: - Journal of Clinical Oncology. 38(13):1419-1428, 2020 05 01.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Anderson GL, Aragaki AK, Barac A, Chlebowski RT, Johnson KC, Lane DS, Luo J, Manson JE, Mossavar-Rahmani Y, Neuhouser ML, Pan K, Prentice RL, Rohan TE, Snetselaar L, Thomson CA, Wactawski-Wende J, Women's Health Initiative
|
|
99.
|
|
|
100.
|
Breast Surgery in the Time of Global Pandemic: Benefits of Same-Day Surgery for Breast Cancer Patients Undergoing Mastectomy with Immediate Reconstruction during COVID-19. MedStar authors:
- Fan, Kenneth L
- Greenwalt, Ian T
Year: 2020
Citation: - Plastic & Reconstructive Surgery. 146(4):522e-523e, 2020 10.
Institution: - MedStar Washington Hospital Center
Department:
- MedStar Georgetown University Hospital Residents
- Surgery/Plastic Surgery
Medline publication type:
All authors: - Bartholomew AJ, Fan KL, Greenwalt IT, King CA, Lovett BL, Perez-Alvarez IM, Song DH, Tousimis EA
|